Low‐Density Lipoprotein Receptor on Endothelium of Brain Capillaries
Abstract
Abstract: The presence of lipoproteins, apolipoproteins, and their receptors in the brain could provide a system for cholesterol homeostasis, as they do in other tissues. This study was undertaken to determine whether plasma low‐density lipoprotein, the major carrier of cholesterol, is involved in the delivery of lipids through the blood‐brain barrier. 125 I‐Labeled low‐density lipoprotein bound to a specific receptor on the endothelium of brain capillaries when it was injected immediately postmortem into bovine brain circulation. In contrast, no specific binding of 125 I‐low density lipoprotein was found when the incubations were performed with isolated capillaries. Incubations of endothelial or basement membranes of brain capillaries with 125 I‐low density lipoprotein demonstrated a high‐affinity association of low‐density lipoprotein with the membranes of bovine cerebral endothelial cells. The specificity of the low‐density lipoprotein binding was determined in several ways using a dot blot assay. This receptor shows the same characteristics as the low‐density lipoprotein receptor on human fibroblasts. The molecular weight of the bovine brain capillary low‐density lipoprotein receptor (132,000) was determined by ligand blotting. These results demonstrated the occurrence of a low‐density lipoprotein receptor on the endothelial cells of brain capillaries.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LRP1 and LRP2 are expressed in brain endothelium and colocalize mainly on the abluminal side of the blood-brain barrier in humans and rodents.
“LRP1 and LRP2 are expressed in brain endothelium and colocalize mainly on the abluminal side of the BBB in humans and rodents (137, 404, 535, 607, 682).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [404]
Cited by
Sorted by citations
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · see citing works
Essential fatty acids in growth and development
Innis, S. M. (1991) · Progress in Lipid Research · doi:10.1016/0163-7827(91)90006-q · Cited by 921 · see citing works
Transcytosis: Crossing Cellular Barriers
TUMA, P. L., & HUBBARD, A. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00001.2003 · Cited by 681 · see citing works
Nanotechnology for protein delivery: Overview and perspectives
Yu, M., Wu, J., Shi, J., & Farokhzad, O. C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.012 · Cited by 410 · see citing works
Sources of eicosanoid precursor fatty acid pools in tissues
Zhou, L., & Nilsson, Å. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32206-9 · Cited by 184 · see citing works
Martel, C. L., Mackic, J. B., Matsubara, E., Governale, S., Miguel, C., Miao, W., McComb, J. G., Frangione, B., Ghiso, J., & Zlokovic, B. V. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051995.x · Cited by 149 · see citing works
Ding, L., Kshirsagar, P., Agrawal, P., & Murry, D. J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060706 · Cited by 62 · see citing works
- Authors
- Méresse, S., Delbart, C., Fruchart, J., & Cecchelli, R.
- Affiliations
- Institut Pasteur (FR)
- Université de Lille (FR)
- Corresponding author
- Cecchelli, Roméo
- ORCID
- Méresse, Stéphane
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1989-08
- Volume
- 53
- Issue
- 2
- Pages
- 340-345
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2170221785
- Cited by
- 143
- References
- 0
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 9 · 2017: 5 · 2016: 1 · 2015: 8 · 2014: 9 · 2013: 1 · 2012: 3
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- LDL receptor, brain capillary endothelium, blood-brain barrier, cholesterol homeostasis, receptor binding, bovine brain, brain endothelial cells, apolipoproteins, receptor molecular weight
- MeSH terms
- Animals, Basement Membrane, Brain, Capillaries, Cattle, Cerebrovascular Circulation, Endothelium, Vascular, Fibroblasts, Lipoproteins, LDL, Receptors, LDL, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review